Search

everythinglearnresearchcommunity

for

Search:↓

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Managing menopause symptoms like skin changes and hair thinning involves hormone therapy, procedures, and skincare, with emotional support being important.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Anti-androgens can help reduce the effects of male hormones on the skin.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Androgens increase cervical cancer risk and affect its development.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Some medications can help increase sexual desire and function in women.